Naltrexone is not known to damage healthy kidneys. There are no documented cases of naltrexone causing kidney injury in people with normal renal function. However, because the kidneys are the primary route for clearing naltrexone from the body, the drug does require caution if you already have kidney problems.
How Naltrexone Passes Through Your Kidneys
Your kidneys do most of the heavy lifting when it comes to eliminating naltrexone. Between 53% and 79% of each dose leaves the body through urine. Very little of the original drug makes it to the kidneys intact, though. Less than 2% of an oral dose shows up in urine as unchanged naltrexone. Instead, your liver converts the drug into a primary breakdown product called 6-beta-naltrexol, which accounts for about 43% of what your kidneys filter out.
This means naltrexone isn’t sitting in kidney tissue in concentrated form. The liver does the metabolic work first, and the kidneys handle excretion of the resulting byproducts. That’s a meaningful distinction: drugs that cause kidney damage typically do so by crystallizing in the kidney or by directly injuring the cells that line the kidney’s filtering units. Naltrexone doesn’t appear to do either.
Why Existing Kidney Disease Changes the Picture
If your kidneys are already impaired, they can’t clear naltrexone and its byproducts efficiently. That creates the potential for the drug and its metabolites to build up in your system, increasing the risk of side effects. The FDA label for naltrexone states plainly that “caution is recommended in administering the drug to patients with renal impairment” and that adequate studies in people with severe kidney disease have not been conducted.
The FDA’s prescribing criteria also note that a candidate for naltrexone should not have “severe or active liver or kidney problems.” This isn’t because naltrexone has been shown to worsen kidney disease. It’s because no one has studied it thoroughly enough in that population to confirm it’s safe. The concern is about drug accumulation, not direct toxicity.
For mild kidney impairment, the picture is more reassuring. Clinical observations suggest that mild impairment does not require dose adjustments. There are no published guidelines specifying exact dose reductions based on kidney filtration rate, which reflects how little clinical evidence exists for moderate or severe cases rather than a sign that the drug is especially dangerous.
Standard Dose vs. Low Dose Naltrexone
Naltrexone is prescribed at 50 mg daily for alcohol or opioid dependence. Low dose naltrexone (LDN), typically 1 to 5 mg, is used off-label for chronic pain and certain inflammatory conditions. The renal burden of LDN is substantially lower simply because the dose is a fraction of the standard amount.
Even so, LDN still undergoes renal clearance. Researchers studying LDN for chronic pain have noted it may be contraindicated in some patients with severe kidney disease for the same accumulation reasons that apply to the full dose. If you’re taking LDN and have reduced kidney function, the same general caution applies, just at a smaller scale.
What Monitoring Looks Like
The FDA label for naltrexone emphasizes liver monitoring more than kidney monitoring. Liver function tests are specifically recommended before and during treatment because naltrexone can cause liver inflammation at high doses. Kidney-specific testing like creatinine or BUN is not explicitly required for patients with healthy kidneys starting naltrexone.
That said, most prescribers will run a basic metabolic panel before starting the medication, which includes kidney function markers. This serves as a baseline to confirm your kidneys are working well enough to handle the drug. If you already have bloodwork showing normal kidney function, naltrexone is unlikely to change that picture. People on long-term naltrexone with healthy kidneys at the outset don’t appear to develop kidney problems as a result of the medication.
The Bottom Line on Kidney Safety
Naltrexone relies on your kidneys to leave your body, but it doesn’t appear to harm them in the process. The risk isn’t that naltrexone will damage your kidneys. The risk is that damaged kidneys can’t clear naltrexone properly, leading to higher-than-intended drug levels. If your kidney function is normal, this medication carries no known renal risk. If you have moderate or severe kidney disease, the lack of clinical data in that population means the drug should be used cautiously, if at all.